About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Slc25a37tm1.2Kapl
targeted mutation 1.2, Jerry Kaplan
MGI:5014804
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Slc25a37tm1.2Kapl/Slc25a37tm1.2Kapl involves: 129S1/Sv * 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr MGI:5014817
cn2
Slc25a37tm1.1Kapl/Slc25a37tm1.2Kapl
Tg(Mx1-cre)1Cgn/?
involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * CBA MGI:5014819
cn3
Slc25a37tm1.1Kapl/Slc25a37tm1.2Kapl
Speer6-ps1Tg(Alb-cre)21Mgn/?
involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * DBA MGI:5014820
cn4
Slc25a37tm1.1Kapl/Slc25a37tm1.2Kapl
Tg(Tek-cre)1Ywa/?
involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * SJL MGI:5014818


Genotype
MGI:5014817
hm1
Allelic
Composition
Slc25a37tm1.2Kapl/Slc25a37tm1.2Kapl
Genetic
Background
involves: 129S1/Sv * 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Slc25a37tm1.2Kapl mutation (0 available); any Slc25a37 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• pale embryos found at E9.5
• no homozygous embryos at E11.5

integument
• E9.5 embryos are noticeably paler than control embryos

hematopoietic system
• no hemoglobinization in the yolk sac and heart




Genotype
MGI:5014819
cn2
Allelic
Composition
Slc25a37tm1.1Kapl/Slc25a37tm1.2Kapl
Tg(Mx1-cre)1Cgn/?
Genetic
Background
involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Slc25a37tm1.1Kapl mutation (0 available); any Slc25a37 mutation (9 available)
Slc25a37tm1.2Kapl mutation (0 available); any Slc25a37 mutation (9 available)
Tg(Mx1-cre)1Cgn mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• increased in the spleen in mice treated with poly (I:C)
• ineffective erythropoiesis in bone marrow and spleen in mice treated with poly (I:C)
• development of anemia in mice treated with poly (I:C)
• 5 fold increase in splenic erythroid progenitor cells in mice treated with poly (I:C)
• 10 fold increase in primitive erythroid progenitor cells in bone marrow
• increased number of non-viable cells in both spleen and bone marrow
• 2 fold increase in bone marrow in mice treated with poly (I:C)
• decreased red blood cell number in mice treated with poly (I:C)
• 50% decrease in mature red blood cell numbers in bone marrow
• in mice treated with poly (I:C)
• in mice treated with poly (I:C)
• in mice treated with poly (I:C)
• 6 fold decrease in cell number in mice treated with poly (I:C)
• four fold decrease in B cell lineage cells in bone marrow
• 4 fold decrease in cell number mice treated with poly (I:C)
• changes in spleen architecture in mice treated with poly (I:C)
• in mice treated with poly (I:C)

immune system
• 6 fold decrease in cell number in mice treated with poly (I:C)
• four fold decrease in B cell lineage cells in bone marrow
• 4 fold decrease in cell number mice treated with poly (I:C)
• changes in spleen architecture in mice treated with poly (I:C)
• in mice treated with poly (I:C)

growth/size/body
• in mice treated with poly (I:C)




Genotype
MGI:5014820
cn3
Allelic
Composition
Slc25a37tm1.1Kapl/Slc25a37tm1.2Kapl
Speer6-ps1Tg(Alb-cre)21Mgn/?
Genetic
Background
involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * DBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Slc25a37tm1.1Kapl mutation (0 available); any Slc25a37 mutation (9 available)
Slc25a37tm1.2Kapl mutation (0 available); any Slc25a37 mutation (9 available)
Speer6-ps1Tg(Alb-cre)21Mgn mutation (6 available); any Speer6-ps1 mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
N
• viability is normal

homeostasis/metabolism
N
• iron and heme metabolism is normal unless fed delta aminolevulinic acid
• increased protoporphyrin IX in liver, plasma, and red blood cells when fed delta aminolevulinic acid

liver/biliary system
• when fed delta aminolevulinic acid
• increased collagen deposition when fed delta aminolevulinic acid, also occurs to a to lesser extent in heterozygotes
• bile accumulation occurs when fed delta aminolevulinic acid

hematopoietic system
• slightly enlarged when fed delta aminolevulinic acid

immune system
• slightly enlarged when fed delta aminolevulinic acid

growth/size/body
• when fed delta aminolevulinic acid
• slightly enlarged when fed delta aminolevulinic acid




Genotype
MGI:5014818
cn4
Allelic
Composition
Slc25a37tm1.1Kapl/Slc25a37tm1.2Kapl
Tg(Tek-cre)1Ywa/?
Genetic
Background
involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Slc25a37tm1.1Kapl mutation (0 available); any Slc25a37 mutation (9 available)
Slc25a37tm1.2Kapl mutation (0 available); any Slc25a37 mutation (9 available)
Tg(Tek-cre)1Ywa mutation (6 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• no live mice can be identified





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory